Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Calliditas Therapeutics AB (publ)
  6. News
  7. Summary
    CALTX   SE0010441584

CALLIDITAS THERAPEUTICS AB (PUBL)

(CALTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Move Lower in Thursday Trading

11/18/2021 | 11:10am EST


© MT Newswires 2021
All news about CALLIDITAS THERAPEUTICS AB (PUBL)
01/14CALLIDITAS THERAPEUTICS : Amendment to Annual Report by Foreign Issuer (Form 20-F/A)
PU
01/10European ADRs Move Lower in Monday Trading
MT
2021Biologics by McKesson - TARPEYOTM (budesonide) delayed release capsules, FDA Approved t..
AQ
2021European ADRs Move Higher in Tuesday Trading
MT
2021European ADRs Move Lower in Monday Trading
MT
2021HC Wainwright Adjusts Calliditas Therapeutics' Price Target to $62 From $52, Reiterates..
MT
2021Citigroup Adjusts Calliditas Therapeutics' Price Target to $84 From $51, Reiterates Buy..
MT
2021AFTER HOURS WATCH LIST SCORECARD : Calt, blbd, irnt
MT
2021CALLIDITAS THERAPEUTICS : FDA grants Calliditas Therapeutics Accelerated Approval of TARPE..
PU
2021Health Care Stocks Marginally Higher on Thursday
MT
More news
Analyst Recommendations on CALLIDITAS THERAPEUTICS AB (PUBL)
More recommendations
Financials
Sales 2021 201 M 21,9 M 21,9 M
Net income 2021 -523 M -56,9 M -56,9 M
Net cash 2021 618 M 67,2 M 67,2 M
P/E ratio 2021 -10,9x
Yield 2021 -
Capitalization 5 266 M 574 M 573 M
EV / Sales 2021 23,1x
EV / Sales 2022 8,73x
Nbr of Employees 65
Free-Float 88,9%
Chart CALLIDITAS THERAPEUTICS AB (PUBL)
Duration : Period :
Calliditas Therapeutics AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CALLIDITAS THERAPEUTICS AB (PUBL)
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 1
Last Close Price 100,60 SEK
Average target price 125,00 SEK
Spread / Average Target 24,3%
EPS Revisions
Managers and Directors
Renée Julie Elisabet Aguiar-Lucander Chief Executive Officer
Fredrik Johansson Chief Financial Officer
Elmar J. Schnee Chairman
Johan Erik Häggblad Chief Scientific Officer
Richard Philipson Chief Medical Officer
Sector and Competitors